Harmonix Fund — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Qu Biologicsqubiologics.com in 𝕏May 2018

Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function.

BiotechHealthtechBurnaby

Harold David Gunn(Executive Officer, Director)Simon Sutcliffe(Chief Medical Officer)Alun Rees(Executive Officer)Robert E. Pelzer(Director)Michael Leschuk(Director)Gillian Vandermeirsch(Executive Officer)

Co-investorsCuritas Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.